SMS Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE812G01025
  • NSEID: SMSPHARMA
  • BSEID: 532815
INR
320.00
4 (1.27%)
BSENSE

Feb 09

BSE+NSE Vol: 5.97 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
210.45
242.43
196.05
248.20
173.35
196.75
164.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
210.45
242.43
196.05
248.20
173.35
196.75
164.45
Raw Material Cost
139.19
106.56
146.66
117.54
118.32
158.77
107.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-25.43
33.26
-35.69
30.37
-32.83
-43.08
-19.28
Employee Cost
21.05
19.25
18.18
26.63
18.64
17.93
16.88
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
21.80
25.74
19.73
25.41
20.75
22.00
18.20
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
10.19
9.26
7.80
7.44
15.26
9.66
7.90
Total Expenditure (Excl Depreciation)
166.80
194.07
156.68
207.39
140.14
165.28
130.94
Operating Profit (PBDIT) excl Other Income
43.65
48.36
39.37
40.81
33.21
31.47
33.51
Other Income
3.75
1.43
0.59
1.42
2.13
1.30
1.37
Operating Profit (PBDIT)
47.40
49.79
39.96
42.23
35.34
32.77
34.88
Interest
6.22
5.74
5.84
5.07
4.20
4.61
4.67
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
41.18
44.05
34.12
37.16
31.14
28.16
30.21
Depreciation
10.02
10.02
9.75
8.64
8.70
8.62
8.38
Profit Before Tax
31.16
34.04
24.37
28.52
22.44
19.54
21.83
Tax
7.97
8.91
5.65
8.44
5.36
5.68
5.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
23.19
25.13
18.71
20.08
17.08
13.86
16.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
23.19
25.13
18.71
20.08
17.08
13.86
16.37
Share in Profit of Associates
0.28
0.18
1.78
0.23
1.16
0.24
0.10
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
23.47
25.31
20.49
20.32
18.24
14.10
16.48
Equity Capital
9.37
9.37
8.87
8.87
8.47
8.47
8.47
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
2.5
2.7
2.31
2.29
2.15
1.66
1.95
Diluted Earnings per share
2.59
2.84
2.31
2.4
2.15
1.67
1.95
Operating Profit Margin (Excl OI)
20.74%
19.95%
20.08%
16.44%
19.16%
15.99%
20.38%
Gross Profit Margin
19.57%
18.17%
17.4%
14.97%
17.96%
14.31%
18.37%
PAT Margin
11.02%
10.37%
9.54%
8.09%
9.85%
7.04%
9.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -13.19% vs 23.66% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -7.27% vs 23.52% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -9.74% vs 22.83% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 8.36% vs -1.71% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of SMS Pharma. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
210.45
521.17
-310.72
-59.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
210.45
521.17
-310.72
-59.62%
Raw Material Cost
139.19
174.26
-35.07
-20.13%
Purchase of Finished goods
0.00
48.93
-48.93
-100.00%
(Increase) / Decrease In Stocks
-25.43
13.91
-39.34
-282.82%
Employee Cost
21.05
99.27
-78.22
-78.80%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
21.80
0.00
21.80
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
10.19
140.02
-129.83
-92.72%
Total Expenditure (Excl Depreciation)
166.80
476.39
-309.59
-64.99%
Operating Profit (PBDIT) excl Other Income
43.65
44.78
-1.13
-2.52%
Other Income
3.75
11.80
-8.05
-68.22%
Operating Profit (PBDIT)
47.40
56.58
-9.18
-16.22%
Interest
6.22
7.42
-1.20
-16.17%
Exceptional Items
0.00
275.52
-275.52
-100.00%
Gross Profit (PBDT)
41.18
324.68
-283.50
-87.32%
Depreciation
10.02
31.25
-21.23
-67.94%
Profit Before Tax
31.16
293.43
-262.27
-89.38%
Tax
7.97
29.14
-21.17
-72.65%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
23.19
264.29
-241.10
-91.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
23.19
264.29
-241.10
-91.23%
Share in Profit of Associates
0.28
0.00
0.28
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
23.47
264.29
-240.82
-91.12%
Equity Capital
9.37
14.08
-4.71
-33.45%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.50
37.54
-35.04
-93.34%
Diluted Earnings per share
2.59
37.47
-34.88
-93.09%
Operating Profit Margin (Excl OI)
20.74%
8.59%
0.00
12.15%
Gross Profit Margin
19.57%
62.30%
0.00
-42.73%
PAT Margin
11.02%
50.71%
0.00
-39.69%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 210.45 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -13.19% vs 23.66% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 21.40% vs 7.35% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 23.47 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -7.27% vs 23.52% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 28.67% vs 58.89% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.65 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -9.74% vs 22.83% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 31.44% vs 14.52% in Dec 2024

Quarterly - Interest
Interest 6.22 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 8.36% vs -1.71% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 48.10% vs -29.41% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.74%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024